NovoCure Ltd. (NVCR)
13.42
+0.12
(+0.90%)
USD |
NASDAQ |
Mar 04, 16:00
13.48
+0.06
(+0.45%)
After-Hours: 20:00
NovoCure Free Cash Flow : -75.68M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| LivaNova Plc | 173.29M |
| AtriCure, Inc. | 48.28M |
| Abbott Laboratories | 7.395B |
| Accuray, Inc. | -10.71M |
| Plus Therapeutics, Inc. | -15.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.00M |
| Cash from Investing (Quarterly) | 336.33M |
| Cash from Financing (Quarterly) | -559.49M |
| Free Cash Flow Per Share (Quarterly) | -0.204 |
| Free Cash Flow to Equity (Quarterly) | 526.69M |
| Free Cash Flow to Firm (Quarterly) | -22.56M |
| Free Cash Flow Yield | -5.06% |